Relay Therapeutics (RLAY) Preferred Shares Issued (2019)

Relay Therapeutics (RLAY) reported Preferred Shares Issued of -$668000.0 for Q4 2019, down 16600.0% quarter-over-quarter from -$4000.0 in Q3 2019.

Relay Therapeutics (RLAY) Preferred Shares Issued (2019) Analysis & Trends

Relay Therapeutics (RLAY) has 1 years of Preferred Shares Issued data on file, last reported at -$668000.0 in Q4 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares Issued (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Relay Therapeutics	2.86 Bn	2.86 Bn	-	-

Download Data